Navigation Links
Schizophrenia Drugs May Spur Subtle Brain Tissue Loss
Date:2/7/2011

MONDAY, Feb. 7 (HealthDay News) -- The use of antipsychotic drugs to treat schizophrenia is associated with the loss of a small but measurable amount of brain tissue, a new study finds.

It included 211 schizophrenia patients who each underwent an average of three MRI brain scans over 7.2 years, for a total of 674 scans in the study group. The researchers then examined how four factors affected changes in brain volume over time: illness duration, illness severity, substance abuse and treatment with antipsychotic drugs.

Longer duration of illness and antipsychotic treatment were both associated with loss of brain tissue. Higher doses of antipsychotics were associated with overall brain tissue loss, reduced gray matter and progressive declines in white matter.

Illness severity and substance abuse had little or no association with brain tissue changes, according to the study, published in the February issue of the Archives of General Psychiatry.

Among young adults, schizophrenia is a leading cause of chronic disability, according to background information in the study. Loss of brain volume in these patients was previously thought to be caused by the illness.

While antipsychotic drugs may lead to brain tissue loss, the benefits of long-term treatment may outweigh the risks, wrote the researchers at the University of Iowa Carver College of Medicine in Iowa City.

"However, our findings point toward the importance of prescribing the lowest doses necessary to control symptoms," they added in a news release from the journal's publisher.

The findings also raise concerns about prescribing antipsychotic drugs for patients with mental health conditions other than schizophrenia, such as bipolar disorder or depression.

The findings shouldn't be seem as a reason to halt the use of antipsychotic drugs to treat schizophrenia, Dr. David A. Lewis, of the University of Pittsburgh, wrote in an accompanying editorial.

"But they do highlight the need to closely monitor the benefits and adverse effects of these medications in individual patients, to prescribe the minimal amount needed to achieve the therapeutic goal, to consider the addition of non-pharmacological approaches that may improve outcomes and to continue the pursuit of new antipsychotic medications with different mechanisms of action and more favorable benefit to harm ratios," he wrote.

More information

The U.S. National Institute of Mental Health has more about schizophrenia.

-- Robert Preidt

SOURCE: JAMA/Archives journals, news release, Feb. 7, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Why symptoms of schizophrenia emerge in young adulthood
2. Mothers flu during pregnancy may increase babys risk of schizophrenia
3. Working-Memory Gene Linked to Schizophrenia
4. Scientists find gene linked to schizophrenia
5. Cold sore virus may contribute to cognitive and brain abnormalities in schizophrenia
6. Brain signs of schizophrenia found in babies
7. New book offers cutting-edge perspective on causes of schizophrenia; related disorders
8. EEG predicts response to medication for schizophrenia
9. Combining medication and psychosocial treatments may benefit patients with early-stage schizophrenia
10. Ming T. Tsuang recognized with NARSAD outstanding achievement award for schizophrenia research
11. Genetic Deletion Linked to Raised Risk of Autism, Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Schizophrenia Drugs May Spur Subtle Brain Tissue Loss 
(Date:7/20/2017)... ... , ... ChenMed , a leading provider of value-based care for seniors, ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family Medicine ... Ambulatory Services for the UVA Health System, brings 30 years of highly relevant experience ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... a telemedicine platform, in which their iMedSecure™ comes included with each system installation. ... encrypted live images to remote participants for real-time collaboration and immediate decision-making requirements. ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... FDAnews Webinar**, Aug. 9, 2017 — 1:30 p.m. – 3:00 p.m. ET, ... inspections and boosting quality. , It’s known as the “CY2016 Annual FDA Medical ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... protection services since 2014, top travel insurance solution company VisitorsCoverage Inc. has launched ... sell all major international travel insurance products online, under their own brand. The ...
(Date:7/20/2017)... ... 19, 2017 , ... At Creekwood Dental Arts, Drs. Donna G. Miller and ... dental implants in Waco, TX, using the latest dental technology for digital ... they can capture details in the oral cavity for accurate diagnoses and customized care ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... MINNEAPOLIS , July 5, 2017 Pace Analytical, a company of ... announcing today that they have acquired ESC Lab Sciences, further solidifying their position ... the United States . ... Steve Vanderboom- President and CEO of Pace Analytical ... of ESC Lab Sciences out of Mt Juliet, TN , ...
(Date:6/30/2017)... , June 30, 2017  AVACEN Medical (AVACEN) announced the ... The research describes the use of its AVACEN Treatment Method ... suffering from fibromyalgia. ... AVACEN Medical ... characterized by chronic widespread pain. It affects approximately 200 to 400 million ...
(Date:6/20/2017)... HILLS, Calif. , June 20, 2017 SkylineDx ... the use of MMprofiler with SKY92, the company,s prognostic ... In a poster presentation at the 22 nd ... Madrid, Spain , SkylineDx researchers will demonstrate ... patients. In a separate e-poster presentation ...
Breaking Medicine Technology: